All patients | Original cohort | Crude analysis OR (95% CI) | Multivariable analysis† AOR (95% CI) | After adjustment of IPW | OR (95% CI)‡ | |||
---|---|---|---|---|---|---|---|---|
Normothermic TTM* | Hypothermic TTM | Normothermic TTM* | Hypothermic TTM | |||||
N = 1217 | N = 369 | N = 848 | N = 1216 | N = 1217 | ||||
Outcome measure | ||||||||
30-day neurological favorable outcome | 445 (36.6) | 135 (36.6) | 310 (36.6) | 1.00 (0.78–1.29) | 1.04 (0.74–1.45) | 438 (36.0) | 448 (36.8) | 1.03 (0.80–1.34) |
30-day survival | 726 (59.7) | 228 (61.8) | 498 (58.7) | 0.88 (0.69–1.13) | 0.92 (0.68–1.24) | 741 (60.9) | 720 (59.2) | 0.93 (0.79–1.09) |